Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moody's Investors Service
Pharma
GLP-1 sales surge to power industry earnings growth: Moody's
Thanks to GLP-1 meds and oncology blockbusters, Moody's has moved its 12- to 18-month industry earnings outlook to "positive."
Zoey Becker
Mar 15, 2024 9:50am
Amgen, J&J to see largest impact from IRA negotiations: Moody's
Sep 7, 2023 9:05am
Obesity drugs carry blockbuster potential, risks for Big Pharma
May 23, 2023 10:10am
Patent cliffs face BMS, Merck, Pfizer but all can pull off M&A
Jun 21, 2022 4:14pm
